Who Buys Asava from India — 173 Importers Behind a $458.0K Market

The importers of Asava from India can be categorized into several segments:

1. Distributors: Entities like REGENCY PHARMA LIMITED (Mauritius) and LUNA TRADING CO. PVT. LTD (Nepal) function as intermediaries, purchasing Asava in bulk to supply to local retailers, healthcare providers, or other businesses. Their buying behavior typically involves large, regular orders to maintain a steady supply chain.

2. Retail Chains: Companies such as SUVEDA INC. D/B/A KERALA AYURVEDA (United States) and KOTTAKKAL AYURVEDIC MEDICALS LLC (United Arab Emirates) operate retail outlets specializing in Ayurvedic products. They procure Asava to stock their shelves, with order patterns influenced by consumer demand and seasonal trends.

3. Re-exporters: Firms like SENTIASA SINAR JAYA RESOURCES (Malaysia) and SUCCESS ADVANCE TRADING (Malaysia) may import Asava with the intent to re-export to neighboring countries or regions. Their purchasing behavior is often characterized by opportunistic buying, capitalizing on market demands in various territories.

4. Contract Manufacturers: Entities such as SWASTHYAM AYURVEDA HANDEL (Germany) might import Asava as a component for further processing or inclusion in proprietary formulations. Their orders are typically aligned with production schedules and client requirements.

Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and optimizing supply chain logistics.

Mauritius

1. Drug Regulatory Authority: Mauritius Pharmacy Board.

2. Import Registration Process: Importers must obtain a pharmaceutical import license from the Mauritius Pharmacy Board, ensuring compliance with local standards and regulations.

3. Estimated Timeline for Registration: The registration process typically takes 4-6 weeks, subject to the completeness of the application and any required inspections.

4. Import Tariff/Duty for HS 30049011: Mauritius imposes a standard import duty of 0% on pharmaceutical products under HS Code 30049011, promoting access to essential medicines.

Nepal

1. Drug Regulatory Authority: Department of Drug Administration (DDA).

2. Import Registration Process: Importers must submit an application to the DDA, including a certified copy of the manufacturer's Good Manufacturing Practices (GMP) compliance, product specifications, lab test reports, and a sample of the drug. (dda.gov.np)

3. Estimated Timeline for Registration: The registration process can take several months, depending on the complexity of the application and the need for additional information or inspections.

4. Import Tariff/Duty for HS 30049011: Nepal imposes an import duty of 14% for SAARC countries and 15% for other countries on pharmaceutical products under HS Code 30049011. (naya.com.np)

Malaysia

1. Drug Regulatory Authority: National Pharmaceutical Regulatory Agency (NPRA).

2. Import Registration Process: Importers must register pharmaceutical products with the NPRA, providing comprehensive documentation, including product details, manufacturing information, and evidence of compliance with international standards. (npra.gov.my)

3. Estimated Timeline for Registration: The registration process typically takes 6-12 months, depending on the product's complexity and the completeness of the application.

4. Import Tariff/Duty for HS 30049011: Malaysia generally imposes a 0% import duty on pharmaceutical products under HS Code 30049011, facilitating access to medicines.

United Arab Emirates (UAE)

1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

2. Import Registration Process: Importers must register pharmaceutical products with MOHAP, submitting detailed documentation, including product composition, manufacturing processes, and compliance with GMP standards.

3. Estimated Timeline for Registration: The registration process can take 6-9 months, subject to the product's nature and the thoroughness of the application.

4. Import Tariff/Duty for HS 30049011: The UAE imposes a 5% import duty on pharmaceutical products under HS Code 30049011, with certain exemptions for essential medicines.

Germany

1. Drug Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

2. Import Registration Process: Importers must obtain a marketing authorization from BfArM, providing extensive documentation, including clinical data, manufacturing details, and proof of compliance with European Union regulations.

3. Estimated Timeline for Registration: The registration process typically takes 12-15 months, depending on the product's complexity and the completeness of the application.

4. Import Tariff/Duty for HS 30049011: Germany, as part of the European Union, imposes a 0% import duty on pharmaceutical products under HS Code 30049011, promoting the availability of medicines.

The demand for Asava in importing countries is driven by several factors:

1. Disease Prevalence: Asava formulations are traditionally used to address various health conditions prevalent in these regions, such as digestive disorders, respiratory issues, and general wellness. The increasing awareness and acceptance of Ayurvedic medicine contribute to sustained demand.

2. Government Healthcare Programs: Many countries are integrating traditional medicine into their national healthcare systems. For instance, Nepal's National Health Policy emphasizes the promotion of Ayurvedic medicine, leading to increased procurement and utilization of products like Asava.

3. Universal Health Coverage Expansion: Countries like Malaysia and Mauritius are expanding their universal health coverage, incorporating alternative and traditional medicines to provide comprehensive healthcare solutions. This expansion creates opportunities for Asava to be included in public health programs.

4. WHO Essential Medicines List Procurement: While Asava may not be listed on the WHO Essential Medicines List, the growing recognition of traditional medicines' role in primary healthcare encourages their inclusion in national essential medicines lists, influencing procurement decisions.

5. Tender-Based Purchasing: Government and private healthcare institutions often procure medicines through tender systems. The repeat buyer rate of 69.4% indicates a stable demand, suggesting that Asava is a preferred choice in such procurement processes.

With 173 buyers across 37 countries, the market for Asava demonstrates a robust and expanding landscape, presenting significant opportunities for growth and increased market penetration.

The importers of Asava from India can be categorized into several segments:

1. Distributors: Entities like REGENCY PHARMA LIMITED (Mauritius) and LUNA TRADING CO. PVT. LTD (Nepal) function as intermediaries, purchasing Asava in bulk to supply to local retailers, healthcare providers, or other businesses. Their buying behavior typically involves large, regular orders to maintain a steady supply chain.

2. Retail Chains: Companies such as SUVEDA INC. D/B/A KERALA AYURVEDA (United States) and KOTTAKKAL AYURVEDIC MEDICALS LLC (United Arab Emirates) operate retail outlets specializing in Ayurvedic products. They procure Asava to stock their shelves, with order patterns influenced by consumer demand and seasonal trends.

3. Re-exporters: Firms like SENTIASA SINAR JAYA RESOURCES (Malaysia) and SUCCESS ADVANCE TRADING (Malaysia) may import Asava with the intent to re-export to neighboring countries or regions. Their purchasing behavior is often characterized by opportunistic buying, capitalizing on market demands in various territories.

4. Contract Manufacturers: Entities such as SWASTHYAM AYURVEDA HANDEL (Germany) might import Asava as a component for further processing or inclusion in proprietary formulations. Their orders are typically aligned with production schedules and client requirements.

Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and optimizing supply chain logistics.

Mauritius

1. Drug Regulatory Authority: Mauritius Pharmacy Board.

2. Import Registration Process: Importers must obtain a pharmaceutical import license from the Mauritius Pharmacy Board, ensuring compliance with local standards and regulations.

3. Estimated Timeline for Registration: The registration process typically takes 4-6 weeks, subject to the completeness of the application and any required inspections.

4. Import Tariff/Duty for HS 30049011: Mauritius imposes a standard import duty of 0% on pharmaceutical products under HS Code 30049011, promoting access to essential medicines.

Nepal

1. Drug Regulatory Authority: Department of Drug Administration (DDA).

2. Import Registration Process: Importers must submit an application to the DDA, including a certified copy of the manufacturer's Good Manufacturing Practices (GMP) compliance, product specifications, lab test reports, and a sample of the drug. (dda.gov.np)

3. Estimated Timeline for Registration: The registration process can take several months, depending on the complexity of the application and the need for additional information or inspections.

4. Import Tariff/Duty for HS 30049011: Nepal imposes an import duty of 14% for SAARC countries and 15% for other countries on pharmaceutical products under HS Code 30049011. (naya.com.np)

Malaysia

1. Drug Regulatory Authority: National Pharmaceutical Regulatory Agency (NPRA).

2. Import Registration Process: Importers must register pharmaceutical products with the NPRA, providing comprehensive documentation, including product details, manufacturing information, and evidence of compliance with international standards. (npra.gov.my)

3. Estimated Timeline for Registration: The registration process typically takes 6-12 months, depending on the product's complexity and the completeness of the application.

4. Import Tariff/Duty for HS 30049011: Malaysia generally imposes a 0% import duty on pharmaceutical products under HS Code 30049011, facilitating access to medicines.

United Arab Emirates (UAE)

1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

2. Import Registration Process: Importers must register pharmaceutical products with MOHAP, submitting detailed documentation, including product composition, manufacturing processes, and compliance with GMP standards.

3. Estimated Timeline for Registration: The registration process can take 6-9 months, subject to the product's nature and the thoroughness of the application.

4. Import Tariff/Duty for HS 30049011: The UAE imposes a 5% import duty on pharmaceutical products under HS Code 30049011, with certain exemptions for essential medicines.

Germany

1. Drug Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

2. Import Registration Process: Importers must obtain a marketing authorization from BfArM, providing extensive documentation, including clinical data, manufacturing details, and proof of compliance with European Union regulations.

3. Estimated Timeline for Registration: The registration process typically takes 12-15 months, depending on the product's complexity and the completeness of the application.

4. Import Tariff/Duty for HS 30049011: Germany, as part of the European Union, imposes a 0% import duty on pharmaceutical products under HS Code 30049011, promoting the availability of medicines.

The demand for Asava in importing countries is driven by several factors:

1. Disease Prevalence: Asava formulations are traditionally used to address various health conditions prevalent in these regions, such as digestive disorders, respiratory issues, and general wellness. The increasing awareness and acceptance of Ayurvedic medicine contribute to sustained demand.

2. Government Healthcare Programs: Many countries are integrating traditional medicine into their national healthcare systems. For instance, Nepal's National Health Policy emphasizes the promotion of Ayurvedic medicine, leading to increased procurement and utilization of products like Asava.

3. Universal Health Coverage Expansion: Countries like Malaysia and Mauritius are expanding their universal health coverage, incorporating alternative and traditional medicines to provide comprehensive healthcare solutions. This expansion creates opportunities for Asava to be included in public health programs.

4. WHO Essential Medicines List Procurement: While Asava may not be listed on the WHO Essential Medicines List, the growing recognition of traditional medicines' role in primary healthcare encourages their inclusion in national essential medicines lists, influencing procurement decisions.

5. Tender-Based Purchasing: Government and private healthcare institutions often procure medicines through tender systems. The repeat buyer rate of 69.4% indicates a stable demand, suggesting that Asava is a preferred choice in such procurement processes.

With 173 buyers across 37 countries, the market for Asava demonstrates a robust and expanding landscape, presenting significant opportunities for growth and increased market penetration.